Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience
Mannini, D.; Aiello, E.; Maver, P.; Corrado, G.; Vecchi, F.; Bellanova, B.
Minerva Urologica e Nefrologica 39(4): 335-341
1987
ISSN/ISBN: 0393-2249 PMID: 2453928 Document Number: 302406
Document emailed within 1 workday
Related Documents
Bentvelsen, F.M.; Bogdanowicz, J.F.; Oosterom, R.; Schröder, F.H. 1990: A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma Nederlands Tijdschrift Voor Geneeskunde 134(33): 1596-1600Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Goncalves, F.; Hornák, M.; Miklosi, M. 1997: Will determination of prostate specific antigen density improve the diagnosis of prostatic carcinoma? Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 76(9): 421-424
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Semjonow, A.; Hertle, L. 1995: Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen? Der Urologe. Ausg. a 34(4): 290-296
Obralic, N.; Kulovac, B.; Aganovic, D.; Junuzovic, D. 2009: Values of prostate specific antigen in patients with operable prostate carcinoma Medicinski Arhiv 63(1): 34-37
Peters, O.; Gorus, F.; De Boeck, M.; Dehou, M.F.; Van Camp, B. 1984: Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma Clinical Chemistry 30(5): 803-804
Sciarra, A.; D'Eramo, G.; Casale, P.; Di Nicola, S.; Di Chiro, C.; De Santis, C.; Loreto, A.; Di Silverio, F. 1999: Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels Minerva Urologica e Nefrologica 51(3): 157-158
Cerović, S.; Dimitrijević, J.; Milović, N.; Ajdinović, B.; Knezević-Usaj, S.; Popović, L.; Brajusković, G. 2002: Prostate-specific antigen in the diagnosis and treatment of carcinoma of the prostate Vojnosanitetski Pregled 59(6 Suppl): 53-57
Grauer, L.S.; Lawler, K.D.; Marignac, J.L.; Kumar, A.; Goel, A.S.; Wolfert, R.L. 1998: Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line Cancer Research 58(21): 4787-4789
Schmid, H.P. 1998: Prostate carcinoma: prostate-specific antigen--and then what? Therapeutische Umschau. Revue Therapeutique 55(7): 426-428
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Ablin, R.J. 1980: Prostate-specific acid phosphatase Clinical Chemistry 26(11): 1632-1633